Legal Representation
Attorney
Peter Nils Baylor
USPTO Deadlines
Next Deadline
959 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-03-04)
Due Date
March 04, 2028
Grace Period Ends
September 04, 2028
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 10, 2014 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| Mar 4, 2008 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 26, 2008 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Jan 26, 2008 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Jun 5, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 3, 2007 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 3, 2007 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 27, 2007 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Nov 28, 2006 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Oct 31, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 11, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Sep 15, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Sep 1, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 25, 2006 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 25, 2006 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 25, 2006 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 25, 2006 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Aug 24, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 20, 2006 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Mar 30, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
Additional Information
Design Mark
The mark consists of the words, NABI BIOPHARMACEUTICALS, and a globe made up varying sizes of shaded dots, with the largest, most closely spaced dots forming the letter "N".
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOPHARMACEUTICALS"